Penumbra, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
PEN New York 3841 www.penumbrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Penumbra, Inc.

Boston Scientific Bets on Growth Through Strategic M&A Deals - May 18th, 2026 12:15 pm
Champlain Sells Out of Freshpet Position, Dumps $125 Million in Stock - May 14th, 2026 11:00 pm
Assessing Penumbra (PEN) Valuation As Growth Expectations Meet A Premium P/E Multiple - May 7th, 2026 1:08 am
Penumbra (PEN) Misses Q1 Earnings Estimates - May 6th, 2026 3:25 pm
Penumbra, Inc. Reports First Quarter 2026 Financial Results - May 6th, 2026 2:05 pm
ALC vs. PEN: Which Stock Should Value Investors Buy Now? - May 5th, 2026 9:40 am
NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry - May 4th, 2026 2:25 pm
Boston Scientific AGM: $20B 2025 Sales, Governance Votes Pass, Special Meeting Proposals Fail - May 1st, 2026 10:08 pm
Massively Disappointing Boston Scientific (BSX) Stock Could Be Due for a Comeback - Apr 28th, 2026 7:31 am
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock - Apr 27th, 2026 10:45 am
Boston Scientific Q1 Earnings Call Highlights - Apr 23rd, 2026 6:07 pm
EY on the current state of the medtech industry - Apr 20th, 2026 9:18 am
Boston Scientific Corporation (BSX) Price Target Lowered at Mizuho Ahead of Q1 Medical Device Earnings - Apr 17th, 2026 7:40 am
Peninsula Energy Limited (ASX:PEN): When Will It Breakeven? - Apr 16th, 2026 11:45 pm
A Look At Boston Scientific (BSX) Valuation After The Penumbra Acquisition And Recent Shareholder Returns - Apr 15th, 2026 5:04 pm
Citi Reiterates Buy rating for Boston Scientific (BSX) - Apr 14th, 2026 12:24 pm
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients - Apr 13th, 2026 7:00 am
1 Mid-Cap Stock on Our Buy List and 2 We Ignore - Apr 13th, 2026 3:48 am
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN) - Apr 10th, 2026 10:45 am
Penumbra Sale To Boston Scientific Sparks Review Of Deal Value - Apr 9th, 2026 9:12 pm